Vaccitech
-
Oxford’s Vaccitech completes IPO on Nasdaq and raises $110.5m
The Oxford-based clinical-stage biopharmaceutical company that co-invented a COVID-19 vaccine is a spin-out from Oxford University’s Jenner Institute.
The Oxford-based clinical-stage biopharmaceutical company that co-invented a COVID-19 vaccine is a spin-out from Oxford University’s Jenner Institute.